Early initiation of SGLT2 inhibitors is important, irrespective of ejection fraction: SOLOIST‐WHF in perspective
Main Authors: | Subodh Verma, Stefan D. Anker, Javed Butler, Deepak L. Bhatt |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | ESC Heart Failure |
Online Access: | https://doi.org/10.1002/ehf2.13148 |
Similar Items
-
WHF Position Statement on COVID Vaccination
by: F. Thienemann, et al.
Published: (2021-04-01) -
WHF IASC Roadmap on Chagas Disease
by: Luis Eduardo Echeverría, et al.
Published: (2020-03-01) -
Effects of SGLT2 inhibitor dapagliflozin in patients with heart failure with reduced ejection fraction
by: N. R. Khasanov
Published: (2020-09-01) -
SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction
by: José Silva-Cardoso, et al.
Published: (2021-09-01) -
The Soloist
by: Darrell C. Ray
Published: (2010-09-01)